Literature DB >> 11796276

Bilateral hand-assisted laparoscopic nephrectomy for autosomal dominant polycystic kidney disease using a single midline HandPort incision.

Michael A Jenkins1, J Jason Crane, Larry C Munch.   

Abstract

OBJECTIVES: To present one of the first known series of bilateral, transperitoneal laparoscopic nephrectomy for autosomal dominant polycystic kidney disease using a hand-assisted technique by way of a single, midline HandPort incision. Synchronous, bilateral nephrectomy for autosomal dominant polycystic kidney disease is an infrequently performed procedure, with only a few reports using laparoscopy.
METHODS: We retrospectively reviewed the charts of 4 patients undergoing bilateral hand-assisted laparoscopic nephrectomy for symptomatic autosomal dominant polycystic kidney disease between June 2000 and January 2001. Follow-up consisted of chart review and telephone survey.
RESULTS: All 4 patients underwent successful bilateral hand-assisted laparoscopic nephrectomy, with a mean operative time of 286 minutes. This included 1 patient who underwent simultaneous laparoscopic marsupialization of symptomatic hepatic cysts. The average size of the polycystic kidneys removed was 1582 g. Complications included acute tubular necrosis of a renal allograft in 1 patient that resolved spontaneously and retained retroperitoneal cystic fluid that required percutaneous drainage in another patient. All patients did well postoperatively, with complete resolution of their presenting symptoms. Those with renal allografts had stable function at the last follow-up visit.
CONCLUSIONS: Bilateral hand-assisted laparoscopic nephrectomy using a single HandPort incision is a feasible alternative for the removal of symptomatic polycystic kidneys. It offers the advantage of easier identification and control of hilar structures that are often obscured by the distorted renal anatomy. In addition, it allows the simultaneous performance of other intra-abdominal procedures.

Entities:  

Mesh:

Year:  2002        PMID: 11796276     DOI: 10.1016/s0090-4295(01)01461-3

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

1.  A novel approach to bilateral hand-assisted laparoscopic nephrectomy for autosomal dominant polycystic kidney disease.

Authors:  M G Whitten; W Van der Werf; L Belnap
Journal:  Surg Endosc       Date:  2006-01-21       Impact factor: 4.584

Review 2.  Evaluation and management of pain in autosomal dominant polycystic kidney disease.

Authors:  Marie C Hogan; Suzanne M Norby
Journal:  Adv Chronic Kidney Dis       Date:  2010-05       Impact factor: 3.620

3.  Simultaneous laparoscopic nephrectomy in ADPKD.

Authors:  Ramen Kumar Baishya; Prabhat Ranjan; Ravindra B Sabnis; Mahesh R Desai
Journal:  J Minim Access Surg       Date:  2010-07       Impact factor: 1.407

Review 4.  A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Authors:  Niek F Casteleijn; Folkert W Visser; Joost P H Drenth; Tom J G Gevers; Gerbrand J Groen; Marie C Hogan; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

5.  Bilateral hand-assisted laparoscopic renal surgery in the supine position: the spleen at risk.

Authors:  James A Brown; Kashif Siddiqi
Journal:  JSLS       Date:  2011 Jan-Mar       Impact factor: 2.172

6.  Bilateral hand-assisted laparoscopic nephrectomy in adult polycystic kidney disease patients: a UK centre experience.

Authors:  C Mak D K; C P Ilie; A Abedin; L Gommersall; C Luscombe; A Golash
Journal:  J Med Life       Date:  2012-06-18

7.  Laparoscopic Nephrectomy for Massive Kidneys in Polycystic Kidney Disease.

Authors:  Andrea Collini; Roberto Benigni; Giuliana Ruggieri; Prof Mario Carmellini
Journal:  JSLS       Date:  2021 Jan-Mar       Impact factor: 2.172

8.  Hand-assisted laparoscopic nephrectomy for polycystic kidney disease.

Authors:  Mary Eng; Christopher M Jones; Robert M Cannon; Michael R Marvin
Journal:  JSLS       Date:  2013 Apr-Jun       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.